Skip to main content Accessibility help

Efficacy of corticosteroids for cancer-related fatigue: A pilot randomized placebo-controlled trial of advanced cancer patients

  • Kenji Eguchi (a1), Michitaka Honda (a2), Tatusji Kataoka (a3), Taketo Mukouyama (a4), Satoru Tsuneto (a5), Junichi Sakamoto (a6), Koji Oba (a7) and Shigetoyo Saji (a8)...



Cancer-related fatigue (CRF) is a common and one of the most important issues in palliative medicine, and it has been demonstrated to have a significant impact on patient quality of life (QoL). The present pilot randomized controlled study evaluated the efficacy and toxicity of methylprednisolone (MP) for CRF in advanced cancer patients.


Our study was planned as a randomized, double-blind, multicenter, placebo-controlled trial. Patients were randomly assigned to an MP group, who received 32 mg/day of MP orally for 7 days, and a placebo group. The primary endpoint was an improvement in visual analog scale (VAS) score for fatigue from baseline to day 7. The secondary endpoints were improvements in appetite loss and QoL as well as evaluating the safety of corticosteroids as palliative therapy.


It was not possible to complete patient registration. In total, 35 patients were randomly assigned to an MP group (n = 18) and a placebo group (n = 17). The mean changes in VAS score for fatigue were –9.06 in the placebo group and –1.56 in the MP group, and for appetite loss –6.44 in the placebo group and –8.06 in the MP group. In addition, there was no evidence that methylprednisolone improved appetite loss or QoL compared to placebo. The incidence of adverse effects was not greater in the MP group.

Significant of Result:

We conclude that our sample size was too small to prove the efficacy of methylprednisolone in improving fatigue. Our results were reported as a pilot study performed to support a subsequent larger trial.


Corresponding author

Address correspondence and reprint requests to: Michitaka Honda, Department of Gastroenterological Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan. E-Mail:


Hide All
Andrykowski, M.A., Schmidt, J.E., Salsman, J.M., et al. (2005). Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology, 23(27), 66136622.
Armes, J., Chalder, T., Addington-Hall, J., et al. (2007). A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue. Cancer, 110(6), 13851395.
Bruera, E., Kuehn, N., Miller, M.J., et al. (1991). The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care, 7(2), 69.
Bruera, E., Driver, L., Barnes, E.A., et al. (2003). Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. Journal of Clinical Oncology, 21(23), 44394443.
Bruera, E., Yennurajalingam, S., Palmer, J.L., et al. (2013). Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: A randomized, placebo-controlled, phase II trial. Journal of Clinical Oncology, 31(19), 24212427.
Campos, M.P., Hassan, B.J., Riechelmann, R., et al. (2011). Cancer-related fatigue: A review. Revista da Associação Médica Brasileira, 57(2), 211219.
Cella, D., Davis, K., Breitbart, W., et al. (2001). Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology, 19(14), 33853391.
Chang, V.T., Hwang, S.S. & Feuerman, M. (2000). Validation of the Edmonton Symptom Assessment Scale. Cancer, 88(9), 21642171.
Debb, S.M., Arnold, B., Perez, B., et al. (2011). Validation of the FACT–Gastric cancer quality of life questionnaire for use in Spanish-speaking countries. Psycho-Oncology, 20(1), 1927.
Esquerdo, G., Llorca, C., Cervera, J.M., et al. (2011). Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia: Relationship between variation in three fatigue-specific quality-of-life questionnaire scores and change in haemoglobin level. Clinical & Translational Oncology, 13(5), 341347. (2010). Functional Assessment of Chronic Illness Therapy. Available at
Fernandes, R., Stone, P., Andrews, P., et al. (2006). Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: Evaluation of diagnostic criteria for cancer-related fatigue. Journal of Pain and Symptom Management, 32(3), 245254.
Groenvold, M., Petersen, M.A., Aaronson, N.K., et al. (2006). The development of the EORTC QLQ–C15–PAL: A shortened questionnaire for cancer patients in palliative care. European Journal of Cancer, 42(1), 5564.
Johnson, R.L., Block, I., Gold, M.A., et al. (2010). Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psycho-Oncology, 19(9), 955958.
Kurihara, M., Shimizu, H., Tsuboi, K., et al. (1999). Development of quality of life questionnaire in Japan: Quality of life assessment of cancer patients receiving chemotherapy. Psycho-Oncology, 8(4), 355363.
Levy, M.H., Adolph, M.D., Back, A., et al. (2012). Palliative care. Journal of the Nationall Comprehensive Cancer Network, 10(10), 12841309.
Mendoza, T.R., Wang, X.S., Cleeland, C.S., et al. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer, 85(5), 11861196.
Minton, O., Richardson, A., Sharpe, M., et al. (2010). Drug therapy for the management of cancer-related fatigue. The Cochrane Database of Systematic Reviews, (7), CD006704.
Revicki, D.A., Stull, D., Vernon, M., et al. (2012). Assessing the effect of darbepoetin alfa on patient-reported fatigue in chemotherapy-induced anemia in four randomized, placebo-controlled clinical trials. Quality of Life Research, 21(2), 311321.
Sarhill, N., Walsh, D., Nelson, K.A., et al. (2001). Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study. The American Journal of Hospice & Palliative Care, 18(3), 187192.
Schneider, C.M., Hsieh, C.C., Sprod, L.K., et al. (2007). Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment. Cancer, 110(4), 918925.
Wewers, M.E. & Lowe, N.K. (1990). A critical review of visual analogue scales in the measurement of clinical phenomena. Research in Nursing & Health, 13(4), 227236.
Yeh, E.T., Lau, S.C., Su, W.J., et al. (2011). An examination of cancer-related fatigue through proposed diagnostic criteria in a sample of cancer patients in Taiwan. BMC Cancer, 11, 387.
Yennurajalingam, S., Frisbee-Hume, S., Palmer, J.L., et al. (2013). Reduction of cancer-related fatigue with dexamethasone: A double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology, 31(25), 30763082.


Efficacy of corticosteroids for cancer-related fatigue: A pilot randomized placebo-controlled trial of advanced cancer patients

  • Kenji Eguchi (a1), Michitaka Honda (a2), Tatusji Kataoka (a3), Taketo Mukouyama (a4), Satoru Tsuneto (a5), Junichi Sakamoto (a6), Koji Oba (a7) and Shigetoyo Saji (a8)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed